Cullinan Oncology (CGEM) Financial Statements

Price: $8.02
Market Cap: $469.27M
Avg Volume: 450.11K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: -0.114
52W Range: $7.9-30.189
Website: Cullinan Oncology

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Cullinan Oncology.


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$20.00M$20.00M$15.00M$15.00M$10.00M$10.00M$5.00M$5.00M$0.00$0.00201920192020202020212021202220222023202320242024
Operating Expenses
Operating Income
Operating Expenses & Income$200.00M$200.00M$100.00M$100.00M$0.00$0.00-$100.00M-$100.00M-$200.00M-$200.00M201920192020202020212021202220222023202320242024
Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Revenue $- $- $18.94M $- $- $-
Cost of Revenue $310.00K $93.00K $53.00K $62.00K $70.00K $43.00K
Gross Profit $-310.00K $-93.00K $18.89M $-62.00K $-70.00K $-43.00K
Gross Profit Ratio 0.00% 0.00% 99.70% 0.00% 0.00% 0.00%
Research and Development Expenses $148.16M $91.95M $57.75M $43.21M $16.79M $9.58M
General and Administrative Expenses $42.49M $40.19M $29.15M $17.12M $5.48M $5.00M
Selling and Marketing Expenses $- $- $- $- $- $-
Selling General and Administrative Expenses $42.49M $40.19M $29.15M $17.12M $5.48M $5.00M
Other Expenses $440.00K $57.00K $-8.00K $-11.00K $-4.00K $-
Operating Expenses $191.09M $132.14M $86.90M $60.34M $22.27M $14.59M
Cost and Expenses $191.09M $132.14M $86.90M $60.34M $22.27M $14.59M
Interest Income $21.63M $6.61M $477.00K $888.00K $620.00K $397.00K
Interest Expense $- $- $- $- $- $-
Depreciation and Amortization $310.00K $93.00K $53.00K $62.00K $70.00K $43.00K
EBITDA $-190.34M $151.41M $-67.90M $-60.27M $-22.20M $-14.54M
EBITDA Ratio 0.00% 0.00% -358.73% 0.00% 0.00% 0.00%
Operating Income $-191.09M $144.65M $-67.95M $-60.34M $-22.27M $-14.59M
Operating Income Ratio 0.00% 0.00% -358.73% 0.00% 0.00% 0.00%
Total Other Income Expenses Net $21.87M $6.67M $469.00K $877.00K $616.00K $397.00K
Income Before Tax $-169.22M $151.32M $-67.48M $-59.46M $-21.65M $-14.19M
Income Before Tax Ratio 0.00% 0.00% -356.25% 0.00% 0.00% 0.00%
Income Tax Expense $-14.12M $42.12M $-2.44M $-8.61M $-1.62M $397.00K
Net Income $-153.16M $111.21M $-65.04M $-50.85M $-20.04M $-14.19M
Net Income Ratio 0.00% 0.00% -343.35% 0.00% 0.00% 0.00%
EPS $-3.69 $2.46 $-1.47 $-1.17 $-0.46 $-1.24
EPS Diluted $-3.69 $2.38 $-1.47 $-1.17 $-0.46 $-1.24
Weighted Average Shares Outstanding 41.51M 45.16M 44.29M 43.52M 43.52M 11.45M
Weighted Average Shares Outstanding Diluted 41.55M 46.64M 44.29M 43.52M 43.52M 11.45M
SEC Filing Source Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$800.00M$800.00M$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.0020192019202020202021202120222022202320232024202420252025
Equity$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.00-$200.00M-$200.00M20192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Cash and Cash Equivalents $83.00M $98.43M $550.12M $430.86M $168.20M $63.25M $33.83M
Short Term Investments $315.97M $368.63M $311.14M $230.69M $42.01M $35.38M $-
Cash and Short Term Investments $398.98M $467.07M $550.12M $430.86M $210.21M $98.63M $33.83M
Net Receivables $- $- $- $- $- $- $-
Inventory $- $- $- $- $- $- $-
Other Current Assets $15.69M $13.12M $7.18M $12.20M $4.14M $1.46M $387.00K
Total Current Assets $414.67M $480.19M $474.47M $296.56M $212.28M $100.09M $34.22M
Property Plant Equipment Net $2.35M $3.53M $5.30M $77.00K $130.00K $182.00K $233.00K
Goodwill $- $- $- $- $- $- $-
Intangible Assets $- $- $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $- $- $-
Long Term Investments $204.44M $- $80.88M $140.40M $- $- $-
Tax Assets $- $- $- $- $- $- $-
Other Non-Current Assets $366.00K $459.00K $459.00K $147.00K $2.30M $188.00K $188.00K
Total Non-Current Assets $207.16M $3.99M $86.64M $140.62M $2.43M $370.00K $421.00K
Other Assets $- $- $- $- $- $- $-
Total Assets $621.82M $484.18M $561.12M $437.19M $214.71M $100.46M $34.64M
Account Payables $1.68M $2.49M $2.66M $3.17M $9.68M $934.00K $296.00K
Short Term Debt $1.30M $1.44M $1.60M $- $- $- $-
Tax Payables $- $- $4.28M $- $- $- $-
Deferred Revenue $- $- $- $- $- $- $-
Other Current Liabilities $27.66M $24.20M $13.96M $8.58M $4.64M $1.59M $1.03M
Total Current Liabilities $30.65M $28.14M $22.50M $11.75M $14.32M $2.52M $1.32M
Long Term Debt $849.00K $2.15M $3.59M $- $- $- $-
Deferred Revenue Non-Current $- $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $- $- $-
Other Non-Current Liabilities $- $- $- $65.00K $74.00K $137.85M $53.97M
Total Non-Current Liabilities $849.00K $2.15M $3.59M $65.00K $276.73M $137.85M $53.97M
Other Liabilities $- $- $- $- $- $- $-
Total Liabilities $31.50M $30.29M $26.09M $11.81M $291.05M $140.37M $55.29M
Preferred Stock $- $- $- $- $276.65M $137.77M $53.90M
Common Stock $6.00K $4.00K $5.00K $4.00K $1.00K $1.00K $1.00K
Retained Earnings $-368.24M $-200.86M $-47.70M $-158.91M $-93.34M $-41.54M $-20.87M
Accumulated Other Comprehensive Income Loss $-133.00K $-129.00K $-2.60M $-838.00K $-2.00K $-4.00K $1.00K
Other Total Stockholders Equity $958.70M $654.68M $585.32M $584.71M $15.70M $-137.77M $-53.90M
Total Stockholders Equity $590.33M $453.70M $535.03M $422.58M $-77.64M $-40.77M $-20.65M
Total Equity $590.33M $453.89M $535.03M $422.98M $-76.34M $-39.91M $-20.65M
Total Liabilities and Stockholders Equity $621.82M $484.18M $561.12M $434.79M $214.71M $100.46M $34.64M
Minority Interest $- $192.00K $- $403.00K $1.30M $864.00K $1.00K
Total Liabilities and Total Equity $621.82M $484.18M $561.12M $434.79M $214.71M $100.46M $34.64M
Total Investments $520.41M $368.63M $392.02M $371.09M $42.01M $35.38M $-
Total Debt $2.15M $3.59M $5.19M $- $- $- $-
Net Debt $-80.85M $-94.84M $-544.93M $-430.86M $-168.20M $-63.25M $-33.83M

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$300.00M$300.00M$200.00M$200.00M$100.00M$100.00M$0.00$0.00-$100.00M-$100.00M-$200.00M-$200.00M-$300.00M-$300.00M-$400.00M-$400.00M20192019202020202021202120222022202320232024202420252025
Financing Cash Flow$280.00M$280.00M$210.00M$210.00M$140.00M$140.00M$70.00M$70.00M$0.00$0.00-$70.00M-$70.00M20192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Net Income $-167.57M $-153.16M $109.19M $-67.48M $-59.46M $-21.65M $-14.19M
Depreciation and Amortization $306.00K $310.00K $93.00K $53.00K $62.00K $70.00K $43.00K
Deferred Income Tax $- $- $- $3.10M $233.00K $-4.00K $-
Stock Based Compensation $37.82M $30.44M $27.96M $24.38M $14.91M $17.00K $-
Change in Working Capital $-389.00K $-339.00K $11.18M $-3.54M $6.85M $135.00K $345.00K
Accounts Receivables $- $- $- $- $- $- $-
Inventory $- $- $- $- $- $- $-
Accounts Payables $-812.00K $-167.00K $-509.00K $-4.83M $5.58M $639.00K $225.00K
Other Working Capital $423.00K $-172.00K $11.69M $1.29M $1.27M $-504.00K $120.00K
Other Non Cash Items $-15.47M $-11.52M $-275.08M $67.00K $7.63M $539.00K $252.00K
Net Cash Provided by Operating Activities $-145.30M $-134.28M $-126.66M $-43.43M $-29.77M $-20.90M $-13.55M
Investments in Property Plant and Equipment $- $-208.00K $-1.13M $-589.23K $-10.00K $-20.00K $-261.00K
Acquisitions Net $- $-36.01K $275.00M $923.00K $1.45M $- $-
Purchases of Investments $-721.13M $-373.38M $-377.92M $-525.81M $-69.76M $-35.38M $-
Sales Maturities of Investments $584.82M $409.40M $352.93M $192.04M $62.90M $- $-
Other Investing Activities $- $36.01K $91.00K $-333.77K $-5.41K $-35.38K $-
Net Cash Used for Investing Activities $-136.31M $35.81M $248.97M $-333.77M $-5.42M $-35.40M $-261.00K
Debt Repayment $- $1.82M $-2.20M $- $- $- $-
Common Stock Issued $262.65M $38.39M $6.02K $267.27M $145.45M $85.72M $1.00K
Common Stock Repurchased $- $- $- $- $- $-378.00K $-
Dividends Paid $- $- $- $- $- $- $-
Other Financing Activities $3.54M $538.00K $-23.73M $1.52M $138.88M $85.72M $-30.00K
Net Cash Used Provided by Financing Activities $266.19M $40.75M $-25.93M $268.78M $140.14M $85.72M $-29.00K
Effect of Forex Changes on Cash $- $- $- $- $- $- $-
Net Change in Cash $-15.43M $-57.72M $96.38M $-108.42M $104.95M $29.42M $-13.84M
Cash at End of Period $83.00M $98.43M $156.15M $59.77M $168.20M $63.25M $33.83M
Cash at Beginning of Period $98.43M $156.15M $59.77M $168.20M $63.25M $33.83M $47.67M
Operating Cash Flow $-145.30M $-134.28M $-126.66M $-43.43M $-29.77M $-20.90M $-13.55M
Capital Expenditure $- $-208.00K $-1.13M $-589.23K $-10.00K $-20.00K $-261.00K
Free Cash Flow $-145.30M $-134.48M $-127.80M $-44.02M $-29.78M $-20.92M $-13.81M